Peritumoral matrilin-2 staining may be useful in distinguishing basal cell carcinoma from folliculocentric basaloid proliferation.
Zhengke WangJennifer LeeCatherine BreenThomas RuengerFang XiongRenato GoreshiMing LuSatori IwamotoPublished in: Journal of cutaneous pathology (2022)
Our results suggest that immunolabeling with the matrilin-2 antibody may help distinguish BCCs from FBPs.